Opinion|Videos|June 19, 2024
Exploring the Influence of Administration Routes on Medical Costs and Caregiver Burden
An overview of how disease-modifying treatments for Alzheimer disease can impact medical costs and caregiver burden.
Advertisement
Episodes in this series
Video content above is prompted by the following question(s):
- How might disease-modifying treatments for Alzheimer disease with different treatment duration and route of administration impact medical costs and caregiver burden?
Advertisement
Related to this article
A large propensity-matched study linked outpatient melatonin use to a small reduction in REM sleep in children evaluated for polysomnography.
Advertisement
Advertisement
Trending on AJMC
1
Medicare Part D Ruxolitinib Spending Hits $49.6 Million as Use Surges
2
Peptide Regulation Debate Intensifies After FDA Advisory Panel's Controversial Vote
3
Melatonin Use Linked to Small REM Sleep Reduction in Children
4
FDA Approves Belzutifan-Lenvatinib Combo for Advanced Kidney Cancer
5